Much has been written over a long time about ANP's use for inflammatory diseases. I have just read Platinum Trusts June Quarterly and Bianca Ogden opens up her Commentary chapter with her views about Inflammatory Diseases. She says ........"We are entering the next chapter for inflammatory diseases, and many companies are getting positioned. While there are a number of therapeutic options, none are curative, and response rates as well as the duration of responses need improvement. The landscsape of new drugs in development for anti-inflammatory diseases is vast. Biologics have been a key therapeutic modality in this space, requiring intravenous infusions or frequent injections."
Looks promising for ATL1102 ??
Much has been written over a long time about ANP's use for...
-
- There are more pages in this discussion • 143 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $66.71M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 7158 | 7.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.7¢ | 29288 | 1 |
View Market Depth
| Last trade - 11.45am 26/07/2024 (20 minute delay) ? |
| PER (ASX) Chart |
Day chart unavailable